NAFLD relies on iNKT cells in CDAA-fed mice, a growing number of CXCR3+IFN-γ+T-bet+IL-17A+ iNKT cells is uncovered in NASH patients (159). Here, IL17A is linked to metabolic dysfunction-associated steatotic liver disease.